American journal of respiratory cell and molecular biology · 2026
Pulmonary blood volumes on computed tomography predict residual pulmonary hypertension post-pulmonary endarterectomy.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ghani Hakim, Thillai Muhunthan, Jenkins David, Bussell Elliott, Ruggiero Alessandro, Walsh Simon, Screaton Nicholas, Bunclark Katherine, Cannon John, Sheares Karen, Taboada Dolores, Graves Martin, Toshner Mark, Ng Choo, Pepke-Zaba Joanna
Аннотация
Pulmonary blood volumes (PBVs), currently not assessed by computed tomography pulmonary angiography (CTPA), could provide additional information to routine investigations performed for chronic thromboembolic pulmonary hypertension (CTEPH). We investigated CTPA-based PBVs in evaluating hemodynamic outcome from pulmonary endarterectomy (PEA). A deep learning-based CTPA vascular segmentation model, differentiating arteries and veins, was applied for automated PBV measurements in patients with CTEPH who underwent PEA at the United Kingdom's national CTEPH service. Pulmonary arteries were compartmentalized into "central" (main pulmonary and proximal lobar) and "intrapulmonary." Mean pulmonary arterial pressure >30 mm Hg post-PEA defined "clinically relevant" residual pulmonary hypertension (PH). Logistic regression models applying CTPA-based PBV to identify residual PH were trained and tested on the discovery and validation cohorts, respectively. Paired pre- and postoperative CTPA in the discovery (n = 71) and validation (n = 102) cohorts showed that central pulmonary artery volume and total artery to vein volume ratio (A-VR) decreased and pulmonary vein volume increased with hemodynamic improvement post-PEA. Preoperative central pulmonary artery volume and A-VR helped identify patients at risk for clinically relevant residual PH post-PEA (area under the receiver operating characteristic curve [AUROC], 0.88 and 0.82 in the discovery and validation cohorts, respectively). Postoperative central pulmonary artery volume, A-VR, and pulmonary vein volume helped to noninvasively identify patients without clinically relevant residual PH (AUROC, 0.91 and 0.88 in the discovery and validation cohorts). Automated quantification of CTPA-based PBV at diagnosis can help stratify risk for residual PH in patients managed with PEA. Utilizing CTPA-derived PBV post-PEA to identify patients without residual PH can potentially reduce the need for routine postoperative right heart catheterization.